Intelligent Bio Solutions (INBS) Competitors $1.83 +0.13 (+7.65%) Closing price 03:59 PM EasternExtended Trading$1.84 +0.01 (+0.82%) As of 07:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock INBS vs. ECOR, POCI, NEPH, TMDIF, COCH, DRIO, PYPD, NMTC, BDMD, and LYRAShould you be buying Intelligent Bio Solutions stock or one of its competitors? The main competitors of Intelligent Bio Solutions include electroCore (ECOR), Precision Optics (POCI), Nephros (NEPH), Titan Medical (TMDIF), Envoy Medical (COCH), DarioHealth (DRIO), PolyPid (PYPD), NeuroOne Medical Technologies (NMTC), Baird Medical Investment (BDMD), and Lyra Therapeutics (LYRA). These companies are all part of the "medical equipment" industry. Intelligent Bio Solutions vs. electroCore Precision Optics Nephros Titan Medical Envoy Medical DarioHealth PolyPid NeuroOne Medical Technologies Baird Medical Investment Lyra Therapeutics electroCore (NASDAQ:ECOR) and Intelligent Bio Solutions (NASDAQ:INBS) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, profitability, analyst recommendations, community ranking, dividends, institutional ownership, media sentiment, valuation and risk. Does the media refer more to ECOR or INBS? In the previous week, electroCore and electroCore both had 2 articles in the media. Intelligent Bio Solutions' average media sentiment score of 0.00 beat electroCore's score of -1.00 indicating that Intelligent Bio Solutions is being referred to more favorably in the news media. Company Overall Sentiment electroCore Negative Intelligent Bio Solutions Neutral Is ECOR or INBS more profitable? electroCore has a net margin of -54.40% compared to Intelligent Bio Solutions' net margin of -323.79%. Intelligent Bio Solutions' return on equity of -146.03% beat electroCore's return on equity.Company Net Margins Return on Equity Return on Assets electroCore-54.40% -154.45% -69.16% Intelligent Bio Solutions -323.79%-146.03%-83.62% Which has higher valuation and earnings, ECOR or INBS? Intelligent Bio Solutions has lower revenue, but higher earnings than electroCore. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioelectroCore$26.46M1.61-$18.83M-$1.56-3.69Intelligent Bio Solutions$2.94M4.31-$10.16MN/AN/A Do analysts prefer ECOR or INBS? electroCore currently has a consensus target price of $25.50, indicating a potential upside of 343.48%. Given electroCore's stronger consensus rating and higher probable upside, research analysts plainly believe electroCore is more favorable than Intelligent Bio Solutions.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score electroCore 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Intelligent Bio Solutions 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has more risk & volatility, ECOR or INBS? electroCore has a beta of 0.79, indicating that its stock price is 21% less volatile than the S&P 500. Comparatively, Intelligent Bio Solutions has a beta of 4.58, indicating that its stock price is 358% more volatile than the S&P 500. Do institutionals & insiders believe in ECOR or INBS? 26.7% of electroCore shares are owned by institutional investors. Comparatively, 33.0% of Intelligent Bio Solutions shares are owned by institutional investors. 19.7% of electroCore shares are owned by insiders. Comparatively, 1.5% of Intelligent Bio Solutions shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Does the MarketBeat Community favor ECOR or INBS? electroCore received 167 more outperform votes than Intelligent Bio Solutions when rated by MarketBeat users. Likewise, 62.55% of users gave electroCore an outperform vote while only 0.00% of users gave Intelligent Bio Solutions an outperform vote. CompanyUnderperformOutperformelectroCoreOutperform Votes16762.55% Underperform Votes10037.45% Intelligent Bio SolutionsOutperform VotesNo VotesUnderperform Votes1100.00% SummaryelectroCore beats Intelligent Bio Solutions on 9 of the 15 factors compared between the two stocks. Get Intelligent Bio Solutions News Delivered to You Automatically Sign up to receive the latest news and ratings for INBS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart INBS vs. The Competition Export to ExcelMetricIntelligent Bio SolutionsSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$12.65M$4.39B$5.57B$8.67BDividend YieldN/A42.68%5.27%4.19%P/E RatioN/A28.2027.2020.16Price / Sales4.3170.64412.92162.04Price / CashN/A51.0838.2534.64Price / Book2.295.967.114.72Net Income-$10.16M$67.01M$3.23B$247.80M7 Day Performance14.38%2.64%4.61%3.36%1 Month Performance51.24%18.46%13.35%9.71%1 Year Performance-1.61%18.42%31.75%14.41% Intelligent Bio Solutions Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)INBSIntelligent Bio Solutions0.1096 of 5 stars$1.83+7.6%N/A-12.8%$12.65M$2.94M0.0010Positive NewsECORelectroCore2.3693 of 5 stars$5.01+0.2%$25.50+409.0%-14.8%$37.10M$26.46M-2.7450POCIPrecision Optics0.1187 of 5 stars$4.66+7.8%N/A-25.5%$35.69M$17.63M-7.2780NEPHNephros2.411 of 5 stars$3.13+15.1%$5.00+59.7%+77.2%$33.18M$15.52M-34.7830High Trading VolumeTMDIFTitan MedicalN/A$0.29-0.2%N/A+511.0%$32.73M$17.63M-0.2350Gap UpCOCHEnvoy Medical3.3762 of 5 stars$1.50-1.4%$9.25+516.7%-37.9%$31.99M$212,000.00-1.0934News CoveragePositive NewsGap UpDRIODarioHealth1.6202 of 5 stars$0.70-2.1%$2.00+185.7%-45.0%$31.13M$28.03M-0.74200PYPDPolyPid2.576 of 5 stars$2.95+5.4%$11.33+284.2%-22.9%$30.06MN/A-0.5980News CoverageAnalyst ForecastAnalyst RevisionGap DownHigh Trading VolumeNMTCNeuroOne Medical Technologies2.118 of 5 stars$0.59-3.0%$1.45+144.6%-29.0%$29.54M$5.76M-2.2820High Trading VolumeBDMDBaird Medical InvestmentN/A$4.41+14.5%N/AN/A$29.04M$37.04M0.00N/ALYRALyra Therapeutics2.7719 of 5 stars$20.25+310.8%$100.00+393.8%+15.0%$26.83M$1.19M-13.5950Gap DownHigh Trading Volume Related Companies and Tools Related Companies ECOR Competitors POCI Competitors NEPH Competitors TMDIF Competitors COCH Competitors DRIO Competitors PYPD Competitors NMTC Competitors BDMD Competitors LYRA Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:INBS) was last updated on 6/10/2025 by MarketBeat.com Staff From Our PartnersThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTrump Nominates “Next Elon”Elon's Replacement? You've been told Elon Musk has been forced out of DC. But did you know his successor ha...Altimetry | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredSHOCKING: Musk's Pentagon Secret Mission...It's about a harrowing message discovered on December 16, 2024: "美国军方暗杀名单" It's the reason President Tru...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Intelligent Bio Solutions Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Intelligent Bio Solutions With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy INBS Stock Free INBS Stock Alerts